Navigation Links
Spectral announces second quarter 2009 results
Date:8/13/2009

43 12 Stock-based compensation expense - 22 - 43 Interest on convertible notes payable 41 41 82 82 Unrealized loss on short-term investments 91 - 91 - Changes in non-cash working capital 344 - (39) (167) ----------------------- ----------------------- (44) (185) (605) (579) ----------------------- ----------------------- Financing activities Bank indebtedness (385) 195 - 195 ----------------------- ----------------------- Investing activities Purchase of property, plant and equipment (51) (101) (54) (115) Purchase of commercial instruments (3) - (25) (22) Decrease (increase) in short-term investments 1,001 2 964 (101) Decrease in deferred revenue (43) (5) (86) (8) ----------------------- ----------------------- 904 (104) 799 (246) ----------------------- ----------------------- Increase (decrease) in cash and cash equivalents during the period 475 (94) 194 (630) ----------------------- ----------------------- Cash and cash equivalents - Beginning of period 16 102 297 638 ----------------------- ----------------------- Cash and cash equivalents -
'/>"/>
SOURCE Spectral Diagnostics Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
2. US Patent and Trademark Office Allows CRis Patent Application for Spectral Imaging of Deep Tissue
3. CRi Announces Nuance 2, the Next-Generation Multispectral Imaging System for Brightfield and Fluorescent-Based Microscopy
4. Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
5. Spectral appoints Anthony Bihl to Board of Directors
6. Spectral announces 2007 financial results
7. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
8. Spectrals EAA(TM) to be used in Phase III study for a sepsis anti-endotoxin therapy
9. Spectral and Toray expand collaboration to include new geographic territories
10. Spectral announces presentation of data on improving sepsis patient management with EAA(TM) and Toraymyxin(TM) combination
11. Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... The human skin is the largest organ, ... human body part. Similar to the liver, or heart, the ... repair and grow. Recent reports from the mankatofreepress.com explained how ... as important as other life supporting organs. The article suggests ... cell reproduction, increase the appearance of skin, and fight off ...
(Date:6/18/2013)... 2013 RegeneCure announced today ... AMCA Guided Bone Regeneration (GBR) Dental Membrane as a bone ... common problem encountered when patients have a tooth replaced with ... to house the implant. Consequently there is often a need ... natural bone regenerates. The bone substitute material, in turn, needs ...
(Date:6/18/2013)... June 18, 2013 ... research firm, announces the initiation of full ... biopharmaceutical company developing and marketing products for ...      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... examining the investment merits of BioAlliance Pharma, ...
(Date:6/18/2013)... NESS ZIONA, Israel , June ... developer of complex bulk Active Pharmaceutical Ingredients (APIs), generic and ... delivery systems, announced today that the company has been granted ... Tapentadol is indicated in the US and Europe ... US Patent number 8,410,176 B2 is titled ...
Breaking Biology Technology:Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2
... SAN DIEGO, June 5 Amylin Pharmaceuticals,Inc. (Nasdaq: ... Global,Healthcare Conference in Dana Point on Wednesday, June 11, ... Chief Executive Officer of,Amylin Pharmaceuticals, will be providing a ... cast, and a recording will be made,available following the ...
... June 5 BioTrends Research Group, Inc. is,pleased ... II. The report is based on the results ... in the UK, France, Germany, Italy, and Spain.,The ... hyperphosphatemia,and secondary hyperparathyroidism., In the ESA market, ...
... (Nasdaq: GENZ ), one,of the world,s leading ... devices produced in its Bio-surgery division with software ... Quality Lifecycle,Management. Dyadem,s FMEA-Med, a software solution that ... and quality, and to set,a new standard in ...
Cached Biology Technology:New Study by BioTrends Highlights Practice Management Shifts Among European Nephrologists 2Genzyme Boosts Quality Using Dyadem Quality Lifecycle Management 2Genzyme Boosts Quality Using Dyadem Quality Lifecycle Management 3Genzyme Boosts Quality Using Dyadem Quality Lifecycle Management 4
(Date:6/19/2013)... The PETA International Science Consortium (PISC) is extremely ... of Appeal has upheld a decision that requires ... study in rats. The study will use approximately ... unborn pups to the substance dipropylene glycol methyl ... the European Community,s Regulation on the Registration, Evaluation, ...
(Date:6/19/2013)... the journal Polar Biology, researchers report using DNA from tissues ... new type of killer whale ( Orcinus orca ). ... stranded on a New Zealand beach and a skeleton was ... but it was almost 50 years before this unique form ... and bulbous forehead, was documented alive in the wild. ...
(Date:6/19/2013)... June 19, 2013 A decade-long JDRF-funded study ... Helmholtz Zentrum Mnchen, Germany, is providing a deeper ... risk of developing type 1 diabetes (T1D), highlighting ... for the disease. The study, "Seroconversion to Multiple ... in Children," was published today in The ...
Breaking Biology News(10 mins):New data on islet autoantibodies in young children defines early type 1 diabetes development 2
... 4, chances are that sunburn will be the red glare that ... is no burn, the effects of the sun,s ultraviolet (UV) rays ... in the July 2008 issue of The FASEB Journal , ... more likely to cause skin cancer than the other (UVA). This ...
... Like the proverbial canary in the coal mine, ... changes in the world,s oceans, and the culprit ... Washington conservation biologist. Oil pollution, depletion of ... habitat for many penguin species, along with Earth,s ...
... that light effects the growth and development of plants, ... animals? A new paper by Nathalie Hoang et al., ... this question by examining cryptochromes in flies, mice, and ... and process blue light for functions such as growth, ...
Cached Biology News:Sunburn alert: UVB does more damage to DNA than UVA 2Penguins setting off sirens over health of world's oceans 2Penguins setting off sirens over health of world's oceans 3Penguins setting off sirens over health of world's oceans 4A mammalian clock protein responds directly to light 2
Bovine Brain Microvascular Endothelial Cells (BBMVEC) (>500,000 cells)...
The improved design and new mechanical solutions of Finnpipette Focus Multichannel Plus improves accuracy and precision.In these low volume multichannel pipettes, the super blow-out function ensures ...
... Physical Form: buffered aqueous solution. ... terminal galactose from complex carbohydrates and glycoproteins. ... galactose under conditions where the pH must ... live cells. Unit Definition: ...
... is specific for human cardiac troponin subunit T, ... signals responsible for contraction of cardiac muscle. It ... in human cells. It also cross-reacts with human ... Antigen: Highly purified human cardiac troponin ...
Biology Products: